Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Luc St-Onge

Luc St-Onge

Head of Business Development & Licensing, apceth Biopharma GmbH

Luc St-Onge is Head of Business Development at apceth Biopharma and has over 20 years’ experience in business development and IP in the biopharmaceutical industry. Prior to joining apceth, Luc was Head of Business Development at Ganymed Pharmaceuticals during the acquisition of the company by Astellas Pharma. He is also a co-founder of ARRIDAD Therapeutics, a biotech company developing novel drugs for the treatment of diabetes and autoimmune diseases and was formerly Chief Business Officer at Affectis Pharmaceuticals and Director of Diabetes research at Develogen. Dr. St-Onge is a molecular biologist by training, and has worked with adult and embryonic stem cells during his scientific career. He has published over 25 articles in top journals such as Nature, Oncogene, PNAS, and has filed numerous patent applications.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd